Skip to main content

Find Clinical Trials

Home
Conditions
Solid Tumors

Clinical trial condition

Solid Tumors

Explore clinical trials studying Solid Tumors. Study availability and eligibility vary by location and protocol.

601 public trials 90 recruiting studies

Refine in advanced search Browse all conditions

Solid Tumors trial results

Completed

Phase 1 Study Of Aurora Kinase Inhibitor PF-03814735 In Patients With Advanced Solid Tumors

NCT00424632

Conditions: Solid Tumors
Locations: Pfizer Investigational Site Nashville, Tennessee, United States

Pfizer Investigational Site Leuven, Belgium

View Trial Details

Completed

Karenitecin in Pediatric Patients With Refractory or Recurrent Solid Tumors N10010)

NCT00586560

Conditions: Solid Tumors
Locations: Texas Children's Hospital Houston, Texas, United States

View Trial Details

Completed

Dose Escalation Study of EC D-3263 HCl in Advanced Solid Tumors

NCT00839631

Conditions: Solid Tumors
Locations: South Texas Accelerated Research Therapeutics (START) San Antonio, Texas, United States

View Trial Details

Completed

A Phase I Dose Escalation Study of Oral SB939 Administered Alone or With Azacitidine

NCT00741234

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hematologic Malignancies, +7 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

University of Wisconsin-Madison Madison, Wisconsin, United States

National University Hospital Singapore

National Cancer Center Singapore

View Trial Details

Completed

Genasense as a 2-hour Intravenous Infusion in Subjects With Solid Tumors

NCT00636545

Conditions: Solid Tumors
Locations: South Texas Accelerated Research Therapeutics San Antonio, Texas, United States

View Trial Details

Completed

Pharmacodynamics (PD) and Pharmacokinetics (PK) Study of EP-100 in Advanced Solid Tumors

NCT00949559

Conditions: Advanced Solid Tumors, Solid Tumors
Locations: TGEN Clinical Research Services at Scottsdale Healthcare Scottsdale, Arizona, United States

Mayo Clinic Scottsdale, Arizona, United States

View Trial Details

Completed

Temsirolimus and Pazopanib in Patients With Advanced Solid Tumors

NCT01072890

Conditions: Solid Tumors
Locations: University of California Davis Cancer Center Sacramento, California, United States

View Trial Details

Completed

Target Dosing of Docetaxel Through Pharmacokinetic/Pharmacodynamic Optimisation of the First Chemotherapeutic Cycle

NCT00703378

Conditions: Solid Tumors
Locations: National University Hospital Singapore

View Trial Details

Completed

Phase I Study of IPI-504 and Docetaxel in Patients With Advanced Solid Tumors

NCT00606814

Conditions: Neoplasms, Solid Tumors
Locations: TGen Clinical Research in Scottsdale Scottsdale, Arizona, United States

Yale Cancer Center New Haven, Connecticut, United States

H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States

Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

Safety Study of ASONEP (Sonepcizumab/LT1009) to Treat Advanced Solid Tumors

NCT00661414

Conditions: Neoplasms, Solid Tumors
Locations: Premiere Oncology Scottsdale, Arizona, United States

Pacific Oncology San Diego, California, United States

Premiere Oncology Santa Monica, California, United States

View Trial Details